Procept Biorobotics logo

Procept Biorobotics (PRCT)

$72.99

Procept Biorobotics (PRCT) Share Price Forecast
Currently 15 wall-street analysts regularly analyze the financials of Procept Biorobotics on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Procept Biorobotics (PRCT) have a share price target of $88.5. This median of share price forecast represents a 21.25% upside from the latest price of $72.99 as on 15.10.24.

Procept Biorobotics (PRCT) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Procept Biorobotics (PRCT) share price will touch around $88.5 in next 12-months.
Procept Biorobotics (PRCT) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Procept Biorobotics's share price and its median forecast price. As on 15.10.24, the difference is -13.9%

Procept Biorobotics (PRCT): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Procept Biorobotics (PRCT) Share Price : Analyst Recommendation
Based on 15 analysts tracking and researching Procept Biorobotics (PRCT) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
8
8
8
Outperform
5
5
5
Hold
2
2
2
Underperform
0
0
0
Sell
0
0
0
Procept Biorobotics (PRCT) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Procept Biorobotics (PRCT) is $88.5, offered by 15 analysts offering 12-month price forecasts.

Procept Biorobotics (PRCT) has a maximum of 0.21 upside potential, based on 15 analysts offering 12-month price forecasts.

Based on 15 analysts tracking and researching Procept Biorobotics (PRCT), 86.67% have a buy recommendation. Remaining 13.33% have either sell or hold recommendations.

The latest share price of Procept Biorobotics (PRCT) is $72.99 as of 15/10/2024.

13 of total 15 analysts offering stock ratings for Procept Biorobotics PRCT have recommended buy rating.